BIOMARKERS
Biomarkers for Brain cancer
1. TP53
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. EGFR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. AKT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. Ki-67
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. CDKN2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. IDH1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. ESR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. ERBB2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. MYC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. ER
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. PR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. PTEN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. BCL2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. PIK3CA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. MAPK1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. IDH2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. FBXW7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. MTOR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. BRAF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. AR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. CTLA4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. ABCG2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. hCG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. RB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. JUN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. SMARCB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. APC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. FGFR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. TSC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. NF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. ROS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. FAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. MS4A1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. MUC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. MYCN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. GNAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. STAT3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. NF2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. FANCA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. KDR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. SRC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. TIMP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. SPEN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. IL2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. NTRK1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. VHL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. HIF1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. ENO2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. CEACAM5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. MAX
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. PTCH1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. LDH
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. MDM2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. MEN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. CXCR4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. PRKAR1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. SOX2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. POU5F1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. CDKN1B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. FUS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. TSC2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. AFP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. TG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. MLH1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. CDK4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. PDGFRB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. ITK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. ARID1B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. KIT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. TERT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. ALK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. SDHB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. ATM
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. RHOA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. CCDC6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. MSH2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. BRCA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. DDIT3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. ABL2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. SERPINE1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. OLIG2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. ABL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. KRAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. PDGFRA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. HRAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. PTPRC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. MDM4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. PML
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. MET
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. Beta-hCG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. CREBBP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. BCR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. BRD4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. CALCB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. POLE
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. uPA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. CUX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. RAC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. CD79A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. ATRX
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. PRF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. PSA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. MSH6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. NOTCH1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. NTRK3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. CTNNB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. NRAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. FH
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. BRCA2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. HSP90AA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. RECQL4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. CALR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. RET
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. NKX2-1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. PMS2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. SMO
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. GOPC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. KIAA1549
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. SDHA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. EZH2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. SMAD3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. CDKN2C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. RHOH
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. TP63
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. CDK6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. ERBB3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. EWSR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. WT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. RAF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. NCKIPSD
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. MUC16
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. EP300
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. BLM
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. PDGFB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. U2AF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. PDCD1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. H3F3A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. FLT4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. CCND1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. MAP2K1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. NBN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. PPFIBP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. YWHAE
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. CIC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. CLIP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. CHEK2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. ERCC2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. HMGA2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. SMAD2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. NOTCH2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. MYB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. PTPN11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. CgA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. FOXP3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. CDH1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. NFE2L2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. KMT2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. GATA3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. FGFR3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. IL6ST
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. NDRG1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. ERBB4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. JAK2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. IGH
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. KLF4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. SUFU
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. SDHD
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. STK11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. WAS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. ARNT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. CASP8
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. FOXO3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. SMARCA4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. AKT2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. ELN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. RARA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. CD274
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. EML4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. FUBP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. HIST1H3B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. ZNF198
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. FANCD2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. FGFR2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. HLA-A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. TAL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. ATR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. CARS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. CDH11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. ERG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. AXIN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. FOXO1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. PPM1D
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. CYP2D6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. CYLD
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. SMAD4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. ACVR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. FGFR4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. LMNA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. MYOD1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. TRIM27
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. FES
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. KLK2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. REL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. RUNX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. SALL4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. Neurokinin
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. ETV6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. NT5C2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. FHIT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. MUTYH
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. NSD1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. SND1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. STIL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. FLT3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. KLF6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. PIK3R1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. HER1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. HERPUD1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. HMGA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. LIFR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. STAT5B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. STAT6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. TCF7L2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. WIF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. CBL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. FLI1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. BIRC3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. DICER1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. ELF4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. KMT2D
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. NRG1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. TFE3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. TRB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. TOP2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. FEV
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. GPC3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. HEY1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. AXIN2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. CCND2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. EBF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. ETV5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. GNAQ
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. LEF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. SOCS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. BUB1B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. JAK1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. TCF12
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. TFRC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. TGFBR2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. XPO1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. BCOR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. CTCF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. DAXX
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. DDX3X
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. ERCC4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. NPM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. NUTM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. PAX8
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. SDHC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. SFPQ
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. BCL6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. BCL9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. CRTC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. EIF3E
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. EXT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. GRIN2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. HOXA9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. MAF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. PAX3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. PAX5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. RBM15
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. TNFAIP3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. TRA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. ARID1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. ERCC3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. ERCC5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. LRIG3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. MITF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. MYCL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. MYD88
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. QKI
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. RALGDS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. RPL22
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. TOP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. TPR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. BAP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. CCNE1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. CD74
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. CDX2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. DDX6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. DNMT3A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. EPAS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. FANCC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. MALAT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. NAB2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. PER1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. PLCG1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. POT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. RAD51B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. SYK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. BCL10
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. BTK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. CANT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. CREB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305. DNAJB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
306. HOXD13
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
307. IKZF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
308. MAP2K4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
309. MSN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
310. NONO
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
311. NR4A3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
312. PCSK7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
313. PICALM
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
314. PRCC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
315. SEPT9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
316. SFRP4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
317. TET1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
318. TNFRSF17
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
319. WHSC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
320. XPA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
321. ARHGAP26
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
322. BCL11A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
323. CAMTA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
324. CASC5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
325. COL1A1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
326. CREB3L1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
327. EIF4A2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
328. FAT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
329. FOXA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
330. FOXP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
331. KAT6B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
332. KEAP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
333. KMT2C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
334. LCK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
335. LRP1B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
336. MAP2K2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
337. MKL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
338. MN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
339. MPL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
340. NCOR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
341. NFATC2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
342. NUMA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
343. PRDM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
344. RANBP2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
345. SEPT5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
346. SETD2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
347. SS18
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
348. SUZ12
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
349. TET2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
350. TRAF7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
351. B2M
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
352. BCL11B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
353. CNBP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
354. DUX4L1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
355. EPS15
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
356. ETV1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
357. ETV4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
358. FLCN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
359. FOXO4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
360. GNA11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
361. JAK3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
362. KDM6A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
363. KIF5B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
364. LMO2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
365. LPP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
366. MAP3K1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
367. NCOA2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
368. NCOR2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
369. NFIB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
370. PHOX2B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
371. PIM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
372. PMS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
373. PTPN13
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
374. SDHAF2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
375. SPECC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
376. SSX2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
377. TCF3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
378. TFG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
379. TRRAP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
380. XPC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
381. SET
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
382. AKAP9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
383. ASPSCR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
384. ATF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
385. BCL9L
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
386. BCORL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
387. BMPR1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
388. BRD3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
389. BRIP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
390. BTG1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
391. CCND3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
392. CD79B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
393. CEBPA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
394. CIITA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
395. FAM131B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
396. FGFR1OP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
397. FOXL2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
398. GAS7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
399. HIP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
400. IGL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
401. IRF4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
402. KAT6A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
403. LASP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
404. MALT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
405. MECOM
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
406. MLLT1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
407. MYO5A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
408. PALB2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
409. PAX7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
410. SETBP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
411. SRSF2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
412. SSX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
413. TBX3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
414. TLX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
415. TLX3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
416. TTL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
417. UBR5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
418. USP8
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
419. WRN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
420. ZNF521
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
421. CEP17
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
422. CD52
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
423. ACVR2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
424. AFF3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
425. ALDH2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
426. ARID2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
427. BCL3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
428. CCNB1IP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
429. CDC73
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
430. CHIC2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
431. DDB2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
432. DEK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
433. DROSHA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
434. ELK4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
435. EZR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
436. FANCG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
437. GATA2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
438. H3F3B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
439. HOXA11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
440. HSP90AB1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
441. IL7R
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
442. KDM5A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
443. MED12
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
444. MLLT10
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
445. MLLT11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
446. NCOA4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
447. NFKB2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
448. NUP214
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
449. PBX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
450. PPARG
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
451. PRDM16
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
452. PRKACA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
453. PTK6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
454. PTPRB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
455. RAD21
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
456. RNF213
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
457. RNF43
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
458. RPL5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
459. SDC4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
460. SEPT6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
461. SF3B1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
462. SH2B3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
463. SH3GL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
464. SMARCE1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
465. SPOP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
466. SRGAP3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
467. TBL1XR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
468. TCL1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
469. TFEB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
470. TMPRSS2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
471. TNFRSF14
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
472. TRD
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
473. WWTR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
474. ZFHX3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
475. PAM50
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
476. ACSL6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
477. AFF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
478. APOBEC3B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
479. ASXL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
480. ATIC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
481. ATP1A1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
482. BCL7A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
483. CBFA2T3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
484. CBFB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
485. CHD4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
486. CLTCL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
487. COL2A1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
488. CREB3L2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
489. DDR2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
490. DDX5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
491. DNM2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
492. ERC1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
493. ETNK1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
494. FAT4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
495. GATA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
496. HLF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
497. HNF1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
498. HNRNPA2B1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
499. HOOK3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
500. HOXA13
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
501. IGK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
502. IKBKB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
503. JAZF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
504. KTN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
505. LCP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
506. LMO1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
507. LZTR1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
508. MAFB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
509. MAML2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
510. MLF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
511. MLLT3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
512. MYH9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
513. NACA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
514. NCOA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
515. NIN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
516. NUTM2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
517. OMD
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
518. PAFAH1B2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
519. PBRM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
520. PDE4DIP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
521. PHF6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
522. PLAG1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
523. PRRX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
524. RBM10
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
525. RPL10
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
526. RPN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
527. SLC45A3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
528. SSX4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
529. STRN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
530. TAF15
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
531. TMEM127
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
532. TRIM24
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
533. TRIM33
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
534. TSHR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
535. USP6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
536. ZBTB16
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
537. ZNF331
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
538. WFDC2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
539. FANCE
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
540. ABI1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
541. ACKR3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
542. ACSL3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
543. AFF4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
544. AMER1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
545. ARHGEF12
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
546. ATP2B3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
547. BCL5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
548. C12orf9
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
549. C15orf65
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
550. C2orf44
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
551. CACNA1D
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
552. CARD11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
553. CBLB
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
554. CBLC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
555. CDK12
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
556. CEP89
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
557. CHCHD7
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
558. CLP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
559. CLTC
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
560. CNOT3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
561. CNTRL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
562. COX6C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
563. CRLF2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
564. CRTC3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
565. CSF3R
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
566. DCTN1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
567. DDX10
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
568. ECT2L
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
569. ELL
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
570. EXT2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
571. FAM46C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
572. FANCF
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
573. FBXO11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
574. FCGR2B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
575. FCRL4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
576. FIP1L1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
577. FNBP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
578. FSTL3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
579. GMPS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
580. GOLGA5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
581. GPHN
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
582. HIST1H4I
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
583. HMGN2P46
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
584. HOXC11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
585. HOXC13
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
586. HOXD11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
587. IL21R
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
588. KCNJ5
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
589. KDM5C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
590. KDSR
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
591. KIAA1598
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
592. LHFP
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
593. LSM14A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
594. LYL1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
595. MAP3K13
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
596. MDS2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
597. MLLT4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
598. MLLT6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
599. MNX1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
600. MSI2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
601. MTCP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
602. MYH11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
603. NFKBIE
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
604. NUP98
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
605. NUTM2B
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
606. P2RY8
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
607. PCM1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
608. PDCD1LG2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
609. POU2AF1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
610. PPP2R1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
611. PPP6C
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
612. PREX2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
613. PSIP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
614. PTPRK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
615. PTPRT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
616. PWWP2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
617. RABEP1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
618. RANBP17
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
619. RAP1GDS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
620. RMI2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
621. RNF217-AS1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
622. RSPO2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
623. RSPO3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
624. RUNDC2A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
625. RUNX1T1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
626. SBDS
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
627. SLC34A2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
628. SMARCD1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
629. SRSF3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
630. SS18L1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
631. STAG2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
632. TAL2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
633. TCEA1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
634. TCL6
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
635. TFPT
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
636. THRAP3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
637. TPM3
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
638. TPM4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
639. TRIP11
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
640. VTI1A
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
641. WHSC1L1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
642. ZCCHC8
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
643. ZNF278
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
644. ZNF384
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
645. ZRSR2
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
646. Cytokeratin fragment 21-1
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
647. IHC4
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
648. MAP-Tau mRNA
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
649. MK167
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
650. Nuclear matrix protein 22
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
651. CAD-ALK
[Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]